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Commentary
A seminal environmental health report 
recently presented exposure–response evi-
dence for a major health outcome—cardio-
vascular disease (CVD) mortality—from what 
is unquestionably one of the most important 
global environmental risks in terms of health 
burden, inhalation of combustion particles 
(Pope et al. 2009). Figure 1 shows the pri-
mary results comparing adjusted relative risks 
from ambient air pollution, environmental 
tobacco smoke (ETS, or second-hand smoke), 
and active smoking studies (adapted from 
Pope et al. 2009).
To start, we note several aspects of Figure 1. 
First, presented as estimated average inhaled 
dose of particulate matter ≤ 2.5 μm in aerody-
namic diameter (PM2.5) per day (plotted on 
a log scale), the range of the estimated dose is 
remarkable—nearly three orders of magnitude 
from the lowest estimated doses in ambient air 
pollution studies to the highest from smoking 
studies [this approach for comparing doses 
across such different exposures to combus-
tion particles was suggested by Smith (1987)]. 
Rarely is such a wide range of dose available 
with human data for a noncancer outcome.
Second, although there is some variabil-
ity, the adjusted relative risks show consider-
able consistency over the entire dose range. 
If Figure 1 is accepted, the implications are 
profound. It would seem to belie the com-
mon assertion that the largely aged, fossil 
fuel–derived particles in the ambient atmo-
sphere are very different in terms of health 
effects from those in fresh biomass smoke, 
such as from tobacco burning (Naeher 2007). 
At least in such a macroscale assessment, 
there is little evidence of this. Furthermore, it 
would indicate that the impact of particles on 
CVD mortality risk is highly nonlinear; the 
exposure–response relationship, when plotted 
on a nonlog scale, is much steeper at lower 
doses than it is at higher doses (see Pope et al. 
2009, their Figure 1). The apparently nonlin-
ear exposure–response relationship, previously 
suggested by Cohen et al. (2004) and Ostro 
(2004), could help to explain the implau-
sibly strong risks often noted (Barnoya and 
Glantz 2005; Gambrose and Nicolich 2000; 
Moolgavkar 2005) if one tries to extrapo-
late to higher exposures (e.g., active smok-
ing or occupational exposures) based on risks 
observed for ambient air pollution or ETS 
using a linear response function. Many cig-
arette smokers die from heart disease, but 
not as many as would be expected based on 
directly extrapolating from the risks observed 
for ambient pollution, because the risk of 
death with dose is likely not linear but geo-
metric. Similar questions were raised about 
the higher than expected risks observed for 
ETS and heart disease (based on risks from 
active smoking), but examinations have con-
cluded that the relatively strong risks from 
ETS were indeed plausible (Barnoya and 
Glantz 2005; Howard and Thun 1999).
Nonlinear exposure–response curves with 
similar properties (relatively steep at low 
exposures and leveling off at higher exposures) 
are not uncommon; some examples include 
arsenic and lung cancer (Hertz-Picciotto and 
Smith 1993), cigarette smoking and bladder 
cancer (Vineis et al. 2000), and polycyclic 
aromatic hydrocarbon exposure and DNA 
adducts (Lewtas et al. 1997). Numerous theo-
ries have been postulated regarding the under-
lying mechanism leading to the nonlinear 
shape such as that demonstrated by Pope et al. 
(2009), including exposure misclassification at 
higher exposure levels, competing risks (e.g., 
concurrent increased risk of lung cancer mor-
tality if focusing on smoking and cardiovascu-
lar mortality), preferential avoidance of heavy 
active smoking based on symptoms or sensi-
tivity, decreased inhalation by heavy smokers, 
and biological saturation (Ambrose and Barua 
2004; Goldsmith and Kordysh 1993; Hertz-
Picciotto and Smith 1993; Vineis et al. 2000). 
Ambrose and Barua (2004) suggest that the 
underlying mechanisms, including decreases 
in brachial artery endothelium–  dependent 
vasodilation, abnormalities in nitric oxide 
biosynthesis, and increases in platelet activa-
tion, may become saturated at even relatively 
low doses of cigarette smoke. Although fur-
ther research is needed to elucidate the bio-
logical mechanisms underlying this nonlinear 
response for CVD, the basic shape of the rela-
tionship seems real.
Third, there is an obvious gap in results 
in the range of 1–20 mg/day—that is, greater 
than doses due to ETS exposures but less than 
the lowest doses observed in active smoking 
studies. Does anyone breathe in this gap? 
There are likely occupational settings in which 
such doses occur, although these sometimes 
have unusual types of particles. The most 
obvious populations with exposures in the gap 
are those who depend on biomass and coal 
burning for household cooking and heating in 
poor combustion and ventilation conditions, 
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a situation that characterizes as much as half 
the world population (Mehta et al. 2006). 
For example, equivalent inhaled PM2.5 doses 
among women cooks in these households are 
estimated to be 6–12 mg/day (Saksena et al. 
2003). Unfortunately, however, as yet there 
are no published studies of CVD from this 
household air pollution (HAP), although there 
is some supporting evidence, for example, 
of blood pressure impacts (McCracken et al. 
2007). Based on Figure 1, a relative risk for 
CVD mortality in the range of 1.3–1.6 might 
be expected in these settings with an estimated 
daily dose of 1–20 mg/day compared with 
typical ambient air pollution concentrations 
(e.g., < 10 μg/m3). Combined with the huge 
population exposed at this level from HAP, 
this modest relative risk would indicate a 
major burden of disease globally, even if the 
background heart disease rates are not high in 
the rural populations where these exposures 
typically occur (Wilkinson et al. 2009).
Fourth, the revealed nonlinear relation-
ship for the relative risks implies perhaps a 
counterintuitive progression of health bene-
fits with dose reductions. To illustrate, based 
on Figure 1, we calculated how a population 
of heavy smokers with an estimated dose of 
1,000 mg/day, burdened by 1 million CVD 
deaths, could benefit from shifting to breath-
ing only the particles in the air of one of the 
world’s cleanest cities—an estimated dose of 
0.1 mg/day (an average of ~ 6 μg/m3 assum-
ing an inhalation rate of 18 m3/day), which 
is just below the World Health Organization’s 
(WHO) global annual air quality guideline 
(AQG; WHO 2006) of 10 μg/m3 (~ 0.18 mg/
day), based on the calculation of a population-
attributable fraction at each dose: PAF = f(RR 
– 1)/[ f (RR – 1) + 1], where f is the percentage 
of the population exposed, here assumed to 
be 1, and RR is the relative risk (Murray et al. 
2004). We show three intermediate stages of 
estimated dose: a light smoker, a village cook 
exposed to emissions from biomass burning, 
and a passive smoker, at 100, 10, and 1 mg/
day, respectively. As shown in Figure 2, of 
the about 400,000 total deaths that could be 
averted by the full intervention (shifting heavy 
smokers to nonsmokers living in cities with 
relatively clean air), more than one-third of 
the reduction in deaths accrues at the last step, 
from 1 to 0.1 mg/day. This phenomenon—
greatest risk reduction at the lower end of the 
exposure spectrum—has also been noted for 
active cigarette smoking, where the most ben-
efit is gained from smoking cessation rather 
than from reduction (Godtfredsen et al. 2002, 
2003, 2005; Prescott et al. 2002).
These observations clearly call for addi-
tional work to be done. It would be valuable 
to conduct similar assessments for other out-
comes shared across the range of particle doses 
from cigarette smoking to ambient air, includ-
ing acute respiratory infections, cerebrovascular 
disease, and adverse pregnancy outcomes. We 
suspect that these would show similar nonlinear 
trends over the dose range. Lung cancer, how-
ever, would likely not. Indeed, because relative 
risks > 20 are typically reported for cigarette 
smoking (smokers compared with nonsmokers) 
and relative risks for ambient particles com-
pared with less polluted locations are generally 
around 1.1 (or lower), it is clear that something 
closer to a linear relationship would be found 
for lung cancer. (By comparison, in Figure 1 the 
relative risks over the same dose range for CVD 
range from only about 1.2 to 2.1.)
In addition, the policy implications of the 
nonlinear accrual of health benefits due to 
reduction from high to low doses are difficult 
to grasp. Such a reduction might seem to indi-
cate that, for health protection, it is better to 
emphasize reductions in dose for lightly dosed 
populations. Figure 2 would imply, for exam-
ple, that we could expect much less reduction 
Figure 1. Adjusted relative risks (95% confidence intervals) of cardiovascular and cardiopulmonary mortal-
ity and estimated dose of PM2.5 across studies of outdoor air pollution, ETS, and active cigarette smoking 
(adapted with permission from Pope et al. 2009, their Figure 2). Data on active smoking are from Pope et al. 
(2009); on ETS are from the 2006 Surgeon General’s Report (U.S. Department of Health and Human Services 
2006) and INTERHEART study (Teo et al. 2006); on air pollution are from the Women’s Health Initiative 
cohort (Miller et al. 2007), the American Cancer Society cohort (Pope et al. 1995, 2002, 2004), and the 
Harvard Six Cities cohort (Dockery et al. 1993; Laden et al. 2006). Exposure was measured as daily inhaled 
dose of PM2.5 (plotted on a log scale), calculated assuming 18 m3/day breathing rate. Active cigarette 
smoking was quantified as ≤ 3, 4–7, 8–12, 13–17, 18–22, and ≥ 23 cigarettes/day (relative to never-smokers). 
Also shown is the equivalent dose for the World Health Organization (WHO) (2006) Air Quality Guidelines 
(AQG) for PM2.5 (10 μg/m3 annual average).
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Figure 2. CVD deaths averted by shifting dose categories for inhalation of PM2.5, as measured in estimated 
dose (mg/day). The calculations start with a population of heavy smokers that experiences 1 million CVD 
deaths per year and are based on the population-attributable fraction at each dose level using the rela-
tive risks from Figure 1. As dose decreases, the expected number of CVD deaths decreases as well. For 
example, at equilibrium, the number of annual CVD deaths in this population if shifted to light smokers 
would be 60,000 fewer (940,000 vs. 1 million if heavy smokers) compared with annual deaths if they remain 
heavy smokers.
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in CVD mortality from interventions to per-
suade a population of heavy smokers to smoke 
10 times less than from ambient air pollu-
tion interventions in dirty cities (~ 1.0 mg/day 
or 60 μg/m3 of PM2.5) to bring them to the 
PM2.5 levels of cleaner cities: a reduction of 
about 60,000 deaths compared with 150,000 
deaths in Figure 2. Of course, there are other 
disease end points to consider besides CVD 
and other exposure–response models that fit 
the data nearly as well as the one in Figure 1 
(Pope et al. 2009). Even so, this implication 
would seem to stretch credulity. At the end 
of a year of such interventions, for example, 
the difference in reduced inhaled dose would 
be huge—300 g versus 0.3 g per person. Even 
considering that the biologically relevant depo-
sition factor is likely much lower for heavy 
smokers—less of what is inhaled is deposited 
in the lungs—it still is hard to believe that the 
much larger reduction in material inhaled is 
less beneficial than the relatively smaller reduc-
tion attained by reducing ambient air concen-
trations. The policy choice, of course, would 
also depend on the relative cost and feasibility 
of achieving these various reductions, some of 
which may be quite expensive (e.g., reduction 
of ambient air concentrations to 6 μg/m3).
Finally, because of the potentially large 
health burden it represents, there is need to 
give priority to research programs designed to 
investigate heart disease risks in households 
representing the hundreds of millions of peo-
ple in developing countries with PM doses 
lying in the gap. This could initially be inves-
tigated using case–control and cross-sectional 
studies, but given the increasing incidence of 
heart disease in developing countries, there 
may even be potential for controlled random-
ized trials or other intervention studies in 
populations that have experienced increases in 
co-risk factors (e.g., smoking, obesity, lack of 
exercise) but are still using solid fuels for heat-
ing and/or cooking. Based on an international 
comparative risk assessment for the year 2000, 
indoor air pollution from biomass and coal 
smoke accounted for an estimated 1.6 mil-
lion premature deaths per year worldwide, 
representing 2–3% of the global disease bur-
den (Smith et al. 2004). These estimates were 
based solely on respiratory effects because 
at the time there was no direct evidence for 
cardio  vascular risk. Unfortunately, to this day 
there is still little direct information about 
these risks. CVD is an increasing problem 
worldwide, however, including in many devel-
oping countries where it is now often one 
of the leading causes of death (Reddy 2004; 
Yusuf et al. 2001). Filling in the information 
gap revealed in Figure 1 is critical to fully 
describing the exposure–response relation-
ship of combustion particles across all relevant 
exposures and the consequent total burden of 
disease across all populations in the world.
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